Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance of DS-8500a in healthy subjects
NCT02790684Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2016
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of firuglipel in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Total 14C radioactivity in urine and feces. Started May 2016; status: completed.
02
Drugs
firuglipel
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02790684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790684.